Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 13, 2019

BUY
$42.0 - $59.29 $2.7 Million - $3.82 Million
64,400 Added 180.9%
100,000 $5.14 Million
Q1 2019

May 13, 2019

BUY
$40.82 - $62.45 $481,676 - $736,910
11,800 Added 49.58%
35,600 $2.04 Million
Q4 2018

Feb 12, 2019

SELL
$39.11 - $75.15 $1.02 Million - $1.97 Million
-26,200 Reduced 52.4%
23,800 $998,000
Q2 2018

Aug 13, 2018

BUY
$27.2 - $74.35 $1.36 Million - $3.72 Million
50,000 New
50,000 $3.59 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Ws Management Lllp Portfolio

Follow Ws Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Ws Management Lllp with notifications on news.